Montellier Emilie, Lemonnier Nathanaël, Penkert Judith, Freycon Claire, Blanchet Sandrine, Amadou Amina, Chuffart Florent, Fischer Nicholas W, Achatz Maria-Isabel, Levine Arnold J, Goudie Catherine, Malkin David, Bougeard Gaëlle, Kratz Christian P, Hainaut Pierre
University Grenoble Alpes, Inserm 1209, CNRS 5309, Institute for Advanced Biosciences, F38000 Grenoble, France.
Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
iScience. 2024 Nov 1;27(12):111296. doi: 10.1016/j.isci.2024.111296. eCollection 2024 Dec 20.
Li-Fraumeni syndrome (LFS) is a heterogeneous predisposition to an individually variable spectrum of cancers caused by pathogenic germline variants. We used a clustering method to assign TP53 missense variants to classes based on their functional activities in experimental assays assessing biological p53 functions. Correlations with LFS phenotypes were analyzed using the public germline mutation database and validated in three LFS clinical cohorts. Class A carriers recapitulated all phenotypic traits of fully penetrant LFS, whereas class B carriers showed a slightly less penetrant form dominated by specific cancers, consistent with the notion that these classes identify variants with distinct functional properties. Class C displayed a lower lifetime cancer risk associated with attenuated LFS features, consistent with the notion that these variants have hypomorphic features. Class D carriers showed low lifetime cancer risks inconsistent with LFS definitions. This classification of TP53 variants provides insights into structural/functional features causing pathogenicity.
李-佛美尼综合征(LFS)是一种由致病性种系变异导致的、对个体可变范围癌症的易感性。我们使用一种聚类方法,根据TP53错义变异在评估生物学p53功能的实验分析中的功能活性,将其分类。使用公共种系突变数据库分析与LFS表型的相关性,并在三个LFS临床队列中进行验证。A类携带者重现了完全显性LFS的所有表型特征,而B类携带者表现出一种显性稍低的形式,以特定癌症为主,这与这些类别识别具有不同功能特性的变异的观点一致。C类显示出与LFS特征减弱相关的较低终生癌症风险,这与这些变异具有亚效性特征的观点一致。D类携带者显示出与LFS定义不一致的低终生癌症风险。TP53变异的这种分类为导致致病性的结构/功能特征提供了见解。